South Korea · Delayed Price · Currency is KRW MEDIPOST Company Description
MEDIPOST Co., Ltd. engages in the cord blood bank business in South Korea and internationally.
The company operates through three divisions: Cord Blood Bank, Stem Cell Therapy, and Health Functional Food.
It operates cord blood bank under the CELLTREE name. The company also offers CARTISTEM for the treatment of repetitive and/or traumatic cartilage degeneration, including degenerative osteoarthritis.
In addition, it is developing stem cell products, such as PNEUMOSTEM for the preventative treatment of bronchopulmonary dysplasia.
Further, the company develops SMUP-IA-01 to treat osteoarthritis; and SMUP-IV-01 for the treatment of diabetic nephropathy.
Additionally, it offers nutritional and dietary supplements under the MOVITA brand name; and CDMO services.
The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.
| Country | South Korea |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 328 |
| CEO | Won-il Oh |
Contact Details
Address: 21, Daewangpangyo-ro Seongnam-si South Korea | |
| Phone | 82 2 3465 6677 |
| Website | medi-post.co.kr |
Stock Details
| Ticker Symbol | 078160 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7078160009 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Won-il Oh | Chief Executive Officer |